EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Identifying the ideal candidate for irreversible electroporation in localized prostate cancer: a comprehensive narrative review from the EAU Section of Endourology

Raffaele La Mura iD, Giuseppe Maiolino, Julien Anract iD, Massimo Valerio, Clement Orczyk iD, Ben Vanneste iD, Federico Zorzi iD, João Paulo Barbosa de Oliveira iD, Juan Ignacio Martínez-Salamanca, Eric Barret

BJU International · 2026-12 · 138 (6) · 998-1006

DOI: 10.1111/bju.70436 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift BJU International, online erschienen am 26.08.2026. Verfasst von Raffaele La Mura und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Institut Médico-chirurgical Montsouris, Paris, France. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Irreversible Electroporation Therapy. Die Arbeit nennt 35 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objective Irreversible electroporation (IRE) is an emerging non‐thermal focal therapy for localized prostate cancer (PCa), offering tissue‐selective ablation with functional preservation. This review aimed to delineate the ‘ideal’ candidate for primary IRE and provide practical guidance.

Methods

A narrative review (2014–2025) of primary IRE for localized PCa was conducted, including prospective series, multicentre registries, comparative studies, and systematic reviews. We synthesized baseline characteristics, lesion features, ablation strategy, oncologic/functional outcomes, and complications, focusing on cancer control and safety.

Results

The best outcomes were reported in men with magnetic resonance imaging–visible, organ‐confined intermediate‐risk (International Society for Urological Pathology [ISUP] 2–3) PCa, typically presenting a single dominant unilateral index lesion characterized by multiparametric MRI and biopsy. Contemporary series show in‐field ablation of clinically significant cancer in ~80–90% with high functional preservation. The main limitation is out‐of‐field recurrence (~15–25% of failures), reflecting PCa multifocality. In‐field persistence at 12 months was ~16% in the PRESERVE trial. Lesion size is a key practical constraint; current evidence and electrode geometry favour targets generally ≤20 mm. Limited comparative evidence, largely from a single study, suggests better oncologic control with hemi‐gland IRE (clinically significant PCa persistence 8.6%) versus focal ablation (25%), whereas focal IRE better preserves erectile function. Conclusions and Clinical Implications Primary IRE appears safe and effective in selected localized PCa. The ideal candidate has unilateral MRI‐visible, organ‐confined ISUP 2–3 disease, prostate‐specific antigen density

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsIrreversible Electroporation TherapyMaleHumansElectroporation

Stichwörter der Autor:innen

focal therapyfunctional outcomeshemi‐gland ablationirreversible electroporationpartial‐gland ablationprostate cancer

Autor:innen und Institutionen

  • Department of Urology, Institut Médico-chirurgical Montsouris, Paris, France.
  • Urology Clinic, Department of Medicine and Surgery, University of Perugia, Perugia, Italy.
  • Department of Urology, Cátedra UFV-The Lyx Institution en Salud Urológica, Universidad Francisco de Vitoria, Madrid, Spain.
  • Department of Urology, Hopital Cochin, Paris, France.
  • Department of Urology, Geneva University Hospital, University of Geneva, Geneva, Switzerland.
  • Department of Urology, University College London Hospitals NHS Foundation Trust, London, UK.

ORCID-Profile: Raffaele La Mura, Julien Anract, Clement Orczyk, Ben Vanneste, Federico Zorzi, João Paulo Barbosa de Oliveira

Zitieren

APA

La Mura, R., Maiolino, G., Anract, J., Valerio, M., Orczyk, C., Vanneste, B., Zorzi, F., de Oliveira, J. P. B., Martínez-Salamanca, J. I., & Barret, E. (2026). Identifying the ideal candidate for irreversible electroporation in localized prostate cancer: a comprehensive narrative review from the EAU Section of Endourology. BJU International, 138(6), 998-1006. https://doi.org/10.1111/bju.70436

Vancouver

La Mura R, Maiolino G, Anract J, Valerio M, Orczyk C, Vanneste B, et al. Identifying the ideal candidate for irreversible electroporation in localized prostate cancer: a comprehensive narrative review from the EAU Section of Endourology. BJU International. 2026;138(6):998-1006. doi:10.1111/bju.70436

BibTeX
@article{LaMura2026,
  author = {La Mura, Raffaele and Maiolino, Giuseppe and Anract, Julien and Valerio, Massimo and Orczyk, Clement and Vanneste, Ben and Zorzi, Federico and de Oliveira, João Paulo Barbosa and Martínez-Salamanca, Juan Ignacio and Barret, Eric},
  title = {Identifying the ideal candidate for irreversible electroporation in localized prostate cancer: a comprehensive narrative review from the EAU Section of Endourology},
  journal = {BJU International},
  year = {2026},
  volume = {138},
  number = {6},
  pages = {998--1006},
  doi = {10.1111/bju.70436}
}
Kostenlos starten →